RAMM Pharma Corp. RAMM
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 104.90K | 87.80K | 726.50K | 573.60K | 382.50K |
| Total Receivables | 237.50K | 328.00K | 333.70K | 625.90K | 1.13M |
| Inventory | 228.00K | 537.00K | 645.50K | 661.20K | 1.15M |
| Prepaid Expenses | 15.90K | 9.40K | 13.50K | 19.60K | 12.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.70K | 4.70K | 3.00K | 2.20K | 52.30K |
| Total Current Assets | 590.90K | 966.90K | 1.72M | 1.88M | 2.72M |
|
|
|||||
| Total Current Assets | 590.90K | 966.90K | 1.72M | 1.88M | 2.72M |
| Net Property, Plant & Equipment | 4.20M | 4.27M | 4.51M | 4.73M | 8.07M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.50K | 1.90K | 2.50K | 2.80K | 3.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.79M | 5.24M | 6.23M | 6.61M | 10.79M |
|
|
|||||
| Total Accounts Payable | 125.80K | 119.70K | 142.30K | 271.60K | 354.50K |
| Total Accrued Expenses | 151.20K | 121.90K | 166.90K | 199.40K | 146.10K |
| Short-term Debt | 100.90K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.00K | 32.50K | 45.20K | 49.20K | 20.10K |
| Total Finance Division Other Current Liabilities | 1.72M | 1.77M | 2.27M | 2.02M | 1.31M |
| Total Other Current Liabilities | 1.72M | 1.77M | 2.27M | 2.02M | 1.31M |
| Total Current Liabilities | 2.12M | 2.04M | 2.62M | 2.54M | 1.83M |
|
|
|||||
| Total Current Liabilities | 2.12M | 2.04M | 2.62M | 2.54M | 1.83M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 100.90K | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 8.20K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.12M | 2.04M | 2.62M | 2.55M | 1.83M |
|
|
|||||
| Common Stock & APIC | 48.59M | 50.07M | 50.25M | 48.64M | 49.10M |
| Retained Earnings | -54.70M | -55.73M | -55.72M | -53.39M | -48.89M |
| Treasury Stock & Other | 8.79M | 8.85M | 9.08M | 8.82M | 8.76M |
| Total Common Equity | 2.67M | 3.19M | 3.61M | 4.07M | 8.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.67M | 3.19M | 3.61M | 4.07M | 8.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.67M | 3.19M | 3.61M | 4.07M | 8.96M |
|
|
|||||